Ph.D./M.B.A. Program

An M.B.A. is an investment in the future careers of biomedical graduate students. We know our alums will be future college presidents, department chairs, entrepreneurs, government officials, patent holders, and CEOs of biomedical companies. This program will ensure they leave us not only as cutting-edge scientists, but also prepared for the leadership challenges they will face regardless of what lies ahead.

Regardless of the career trajectory, Ph.D.s can benefit from pursuing a business education. From a practical standpoint, the managerial skills, business acumen, and financial literacy one develops from an MBA program are useful for managing labs, staff, grants, or even starting a business. The biomedical industry and higher education are increasingly influenced by legal issues and shifting healthcare policy, both of which are covered by the M.B.A. curriculum. Students will expand their networks by taking classes alongside CEOs and business leaders enrolled in the Executive M.B.A. program.

The immediate financial advantages of a Ph.D./M.B.A. option at the Miller School are substantial. Not only will accepted students receive 100% tuition waivers for the doctoral portion of their studies, but they will also receive shared credit savings and a 50% scholarship from the School of Business Administration for their M.B.A. In the long-term, students with M.B.A.s can expect to have greater earnings over the lifetime of their careers.